In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma-Reference-Cited by-同舟云学术

In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma

Published:2016-11 Issue:2 Volume:143 Page:379-388
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

AlHilli Mariam M.,Becker Marc A.,Weroha S. John,Flatten Karen S.,Hurley Rachel M.,Harrell Maria I.,Oberg Ann L.,Maurer Matt J.,Hawthorne Kieran M.,Hou Xiaonan,Harrington Sean C.,McKinstry Sarah,Meng X. Wei,Wilcoxen Keith M.,Kalli Kimberly R.,Swisher Elizabeth M.,Kaufmann Scott H.,Haluska Paul

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference40 articles.

1. Integrated genomic analyses of ovarian carcinoma

2. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer;Abkevich;Br. J. Cancer,2012

3. Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas;Pennington;Clin. Cancer Res.,2014

4. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing;Walsh;Proc. Natl. Acad. Sci. U. S. A.,2011

5. Loss of function germline mutations in RAD51D in women with ovarian carcinoma;Wickramanyake;Gynecol. Oncol.,2012

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New hopes and promises in the treatment of ovarian cancer focusing on targeted treatment—a narrative review;Frontiers in Pharmacology;2024-06-14

2. Lestaurtinib’s antineoplastic activity converges on JAK/STAT signaling to inhibit advanced forms of therapy resistant ovarian cancer;2024-06-09

3. Injectable bio-multifunctional hyaluronic acid-based hydrogels loaded with poly ADP-ribose polymerase inhibitors for ovarian cancer therapy;International Journal of Biological Macromolecules;2024-06

4. A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors;Signal Transduction and Targeted Therapy;2023-05-10

5. Targeting homologous recombination deficiency in uterine leiomyosarcoma;Journal of Experimental & Clinical Cancer Research;2023-05-04